CClinicalTrials.gg
CompletedNCT05121623#MedTooFrUpdated Apr 1, 2022

Inappropriate Sexual Behaviour of Patients Towards French General Practitioners

An observational study in Sex Behavior, sponsored by Centre Hospitalier Universitaire de la Réunion. Completed at 1 site in Réunion. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-04-01.

Sponsored by Centre Hospitalier Universitaire de la Réunion · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
570
Ages
18 Years and older
Sex
All
01

Study summary

Occupational sexual harassment (HS) has come to the fore in recent years, particularly with the #MeToo social movement that has encouraged women victims of sexual violence to speak out around the world. The medical profession is not exempt from this phenomenon, whether during the training or professional life of practitioners. In France, very little data is available on this subject, particularly among general practitioners. However, the specific nature of the doctor-patient relationship in general practice makes it a potentially high-risk setting. Furthermore, practitioners' experiences of inappropriate sexual behaviour (ISB) can lead to changes in professional practice, and can thus directly influence the quality of care provided to patients. It is also described in the literature that sexual harassment in physicians is independently associated with a decrease in job satisfaction and sense of security at work, and may be associated with an altered mental health status. To date, the only French studies on ISB and HS in medicine have focused on the period of medical study, and none have looked at the particular problem of the patient as perpetrator of the violence. It is in this context that it has been decided to set up this cross-sectional study with the aim of evaluating the prevalence of ISB occurring during consultations with French general practitioners, to describe their characteristics and to evaluate the responses provided and the repercussions on professional practice.

02

Conditions studied

  • Sex Behavior
03

In context

Lead sponsor

Centre Hospitalier Universitaire de la Réunion is the lead sponsor of 137 studies on the registry; 35 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

General practitioners in private practice in France.

Inclusion criteria

  • Any general practitioner
  • Male or female
  • Sole or mixed private practice
  • Installed or substitute
  • Having completed their internship in general medicine
  • With or without a thesis
  • Practising alone, in a group practice or in a health centre -

Exclusion criteria

Exclusion Criteria:

  • Specialty other than general medicine
  • Exclusive hospital or salaried activity
  • Refusal to participate
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
570 participants (actual)
Patient registry
No

Interventions

  • OtherQuestionnaire

    Online auto-administered Questionnaire

06

What researchers measure

Primary outcomes

  1. Prevalence and nature of inappropriate sexual behaviour of patients towards general practitioners in private practice in France

    Determined by auto-administered questionnaire (sociodemographic data, personal experience, author's characteristics, reactions and answers provided by the practitioners)

    Time frame: Once at the inclusion visit

Secondary outcomes

  1. Prevalence and nature of Inappropriate sexual behavior between men and women

    To compare the prevalence and nature of Inappropriate sexual behavior according to the gender of the responding physicians determined by auto-administered questionnaire

    Time frame: Once at the inclusion visit

Other outcomes

  1. Risk factors associated with sexual inapropriate behavior

    Identify the risk factors associated determined by auto-administered questionnaire (author's characteristics provided by the practitioners)

    Time frame: Once at the inclusion visit

  2. Responses of general practitioners to such a situation

    Types of responses provided by general practitioners to such a situation determined by auto-administered questionnaire (answers provided by the practitioners)

    Time frame: Once at the inclusion visit

  3. Impact and changes on professional practice and personal life.

    Describe the impact and changes on professional practice and personal life determined by auto-administered questionnaire (reactions provided by the practitioners)

    Time frame: Once at the inclusion visit

07

Study locations

1 site
  • CHU de la Réunion
    Saint-Pierre, Réunion
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 1, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05121623
Lead sponsor
Centre Hospitalier Universitaire de la Réunion
Responsible party
Sponsor
First posted
Nov 16, 2021
Start date
Jan 15, 2022
Primary completion
Jan 15, 2022
Completion
Mar 22, 2022
Last update
Apr 1, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion